Drawing for LLS

USPTO serial 97200565

LLS

Reviewed by CopyMark Law Group

Reg. 7376933Status 700Registered
Filing date
Status date
Registration date
May 7, 2024
Examiner
MORAN, CAROLINE L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LLS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles M. Landrum III

Charles M. Landrum III THOMAS HORSTEMEYER, LLP3200 WINDY HILL ROAD, SESUITE 1600EATLANTA, GA 30339

Goods and services

ClassDescriptionStatusFirst use
001Microgel particles used in scientific and medical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 7, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 20, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 31, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 17, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 18, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 16, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 16, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 16, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 6, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 22, 2022AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Nov 21, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 21, 2022IUAAUSE AMENDMENT ACCEPTED—
Nov 18, 2022AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Nov 18, 2022IUAFUSE AMENDMENT FILED—
Nov 17, 2022EAAUTEAS AMENDMENT OF USE RECEIVED—
Aug 23, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 15, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 15, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Feb 15, 2022CNSLSUSPENSION LETTER WRITTEN—
Feb 15, 2022DOCKASSIGNED TO EXAMINER—
Jan 6, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance